Zirconia-toughened alumina biocomponent having high resistance to low temperature degradation and method for preparing same
First Claim
Patent Images
1. A biomedical component comprising zirconia toughened alumina ZTA material, the ZTA material comprising 1-69 wt % ZrO2 , the ZrO2 being partially stabilized with at least 2.1 mol % yttria, and wherein the component has a surface in which the zirconia fraction of the ZTA has a surface monoclinic content of less than 10%.
1 Assignment
0 Petitions
Accused Products
Abstract
A biomedical component comprising zirconia toughened alumina (ZTA), the ZTA comprising 1-69 wt % ZrO2, the ZrO2 being partially stabilized with >2.1 mol % yttria or rare earth oxide, and
wherein the component has a surface in which the zirconia fraction of the ZTA has a surface monoclinic content of less than 10 vol. % (preferably no more than 8 vol. %).
96 Citations
20 Claims
-
1. A biomedical component comprising zirconia toughened alumina ZTA material, the ZTA material comprising 1-69 wt % ZrO2 , the ZrO2 being partially stabilized with at least 2.1 mol % yttria, and
wherein the component has a surface in which the zirconia fraction of the ZTA has a surface monoclinic content of less than 10%.
-
18. A method for preparing a biocomponent comprising a zirconia toughened alumina material ceramic having a resistance to low temperature degradation comprising the following process steps:
-
preparing a powder comprising zirconia and alumina, with a yttria content of more than 2.1 mol. %, sintering at the lowest temperature to insure at least 95% of theoretical density, hot isostatic pressing the already-sintered body in order to reach full density (99% of theoretical density); and
finishing and polishing the working surface in order to reach a surface roughness Ra of less 10 nm, more preferably no more than 5 nm. - View Dependent Claims (19, 20)
-
Specification